Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Farnesyltransferase inhibitor with potential in the treatment of glioblastoma multiforme

June 4, 1998

No Comments

Transurethral alprostadil: conflicting results presented at AUA meeting

June 3, 1998

No Comments

Vasomax phase III results presented at AUA meeting

June 3, 1998

No Comments

Nibentan, a potentially safer class III antiarrhythmic agent

June 2, 1998

No Comments

Venlafaxine: cause of cardiac toxicity identified

June 2, 1998

No Comments

SR-146131, the most potent CCK-A receptor agonist reported to date

June 2, 1998

No Comments

NHE inhibition with dietary cariporide proves beneficial in infarct model

June 2, 1998

No Comments

EMD-96785: a promising cardioprotective agent from Merck KGaA

June 2, 1998

No Comments

Hemodynamic and electrophysiological effects of S-16257 assessed in dogs

June 2, 1998

No Comments

ECG and hemodynamic evaluation of dronedarone, a new antiarrhythmic agent

June 1, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Conferences, BioWorld Science
RSS

Farnesyltransferase inhibitor with potential in the treatment of glioblastoma multiforme

Transurethral alprostadil: conflicting results presented at AUA meeting

Vasomax phase III results presented at AUA meeting

Nibentan, a potentially safer class III antiarrhythmic agent

Venlafaxine: cause of cardiac toxicity identified

SR-146131, the most potent CCK-A receptor agonist reported to date

NHE inhibition with dietary cariporide proves beneficial in infarct model

EMD-96785: a promising cardioprotective agent from Merck KGaA

Hemodynamic and electrophysiological effects of S-16257 assessed in dogs

ECG and hemodynamic evaluation of dronedarone, a new antiarrhythmic agent

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Conferences, BioWorld Science RSS

Conferences, BioWorld Science
RSS